Asosiy kontentga oʻtish
Maqola

Clinical and Metabolic Factors Associated With Liver Fibrosis Risk (Fib-4 >1.3) in Patients With Rheumatoid Arthritis

Mukhabbat SaidovaDSc, Associate Professor of the Bukhara State Medical Institute named after Abu Ali ibn Sina, BukharaFiruz UmarovAssistant of the Bukhara State Medical Institute named after Abu Ali ibn Sina, Bukhara
2026
ABI

Annotatsiya

General Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with extra-articular manifestations, including liver involvement. Specific Background: Liver fibrosis in RA may result from the interaction of inflammatory and metabolic factors. Knowledge Gap: Evidence on clinical and metabolic predictors of liver fibrosis risk in RA remains limited. Aims: This study aimed to identify factors associated with increased liver fibrosis risk (FIB-4 >1.3) in patients with rheumatoid arthritis. Methods: A cross-sectional study was conducted among 156 patients with RA. Clinical, laboratory, and metabolic parameters were analyzed using comparative, correlation, and logistic regression analyses. Results: Elevated FIB-4 was observed in 34.6% of patients. Older age, higher body mass index, elevated aspartate aminotransferase levels, diabetes mellitus, and longer disease duration were significantly associated with increased fibrosis risk and were identified as independent predictors. Novelty: The study highlights the combined role of demographic, metabolic, and biochemical factors in liver fibrosis risk among RA patients. Implications: FIB-4 may serve as a practical non-invasive screening tool to identify patients requiring closer hepatic evaluation and metabolic assessment. Highlights: • Approximately one-third of patients with rheumatoid arthritis exhibited elevated liver fibrosis risk based on FIB-4 assessment.• Older age, higher aspartate aminotransferase levels, greater body mass index, diabetes mellitus, and longer disease duration were independently associated with increased fibrosis risk.• Non-invasive fibrosis screening supports early recognition of hepatic involvement within routine rheumatology practice. Keywords: Rheumatoid Arthritis, Liver Fibrosis, Fibrosis-4 Index, Metabolic Factors, Diabetes Mellitus

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar